Germinal center output is sustained by HELLS-dependent DNA-methylation-maintenance in B cells.
Clara CousuEléonore MulotAnnie De SmetSara FormichettiDamiana LecoeucheJianke RenKathrin MueggeMatthieu BoulardJean-Claude WeillClaude-Agnès ReynaudSébastien StorckPublished in: Nature communications (2023)
HELLS/LSH (Helicase, Lymphoid Specific) is a SNF2-like chromatin remodelling protein involved in DNA methylation. Its loss-of-function in humans causes humoral immunodeficiency, called ICF4 syndrome (Immunodeficiency, Centromeric Instability, Facial anomalies). Here we show by our newly generated B-cell-specific Hells conditional knockout mouse model that HELLS plays a pivotal role in T-dependent B-cell responses. HELLS deficiency induces accelerated decay of germinal center (GC) B cells and impairs the generation of high affinity memory B cells and circulating antibodies. Mutant GC B cells undergo dramatic DNA hypomethylation and massive de-repression of evolutionary recent retrotransposons, which surprisingly does not directly affect their survival. Instead, they prematurely upregulate either memory B cell markers or the transcription factor ATF4, which is driving an mTORC1-dependent metabolic program typical of plasma cells. Treatment of wild type mice with a DNMT1-specific inhibitor phenocopies the accelerated kinetics, thus pointing towards DNA-methylation maintenance by HELLS being a crucial mechanism to fine-tune the GC transcriptional program and enable long-lasting humoral immunity.
Keyphrases
- dna methylation
- wild type
- transcription factor
- genome wide
- gene expression
- immune response
- mouse model
- induced apoptosis
- quality improvement
- working memory
- copy number
- gas chromatography
- dna damage
- air pollution
- type diabetes
- signaling pathway
- cell cycle arrest
- adipose tissue
- circulating tumor
- mass spectrometry
- cell proliferation
- heat shock protein
- genome wide identification